Australia -
English -
Department of Health (Therapeutic Goods Administration)
synagis
abbvie pty ltd - palivizumab -
Singapore -
English -
HSA (Health Sciences Authority)
synagis sterile powder for injection 100 mgvial
abbvie pte. ltd. - palivizumab - injection, powder, for solution - 100 mg/vial (100mg/ml) - palivizumab 100 mg/vial (100mg/ml)
Canada -
English -
Health Canada
synagis powder for solution
abbvie corporation - palivizumab - powder for solution - 50mg - palivizumab 50mg - monoclonal antibodies
Canada -
English -
Health Canada
synagis powder for solution
abbvie corporation - palivizumab - powder for solution - 100mg - palivizumab 100mg - monoclonal antibodies
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
synagis 50mg0.5ml solution for injection vials
abbvie ltd - palivizumab - solution for injection - 100mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
synagis 100mg1ml solution for injection vials
abbvie ltd - palivizumab - solution for injection - 100mg/1ml
Canada -
English -
Health Canada
synagis solution
astrazeneca canada inc - palivizumab - solution - 100mg - palivizumab 100mg - monoclonal antibodies
Canada -
English -
Health Canada
synagis solution
astrazeneca canada inc - palivizumab - solution - 50mg - palivizumab 50mg - monoclonal antibodies
Andorra -
English -
CedimCat (Centre d'Informació de Medicaments de Catalunya)
synagis 100 mg 1 vial pols + 1 ampolla dissolvent